N-[2-(4-Methylphenyl)Ethyl]-N′-[2-(5-Bromopyridyl)]-Thiourea as a Potent Inhibitor of NNRTI-Resistant and Multidrug-Resistant Human Immunodeficiency Virus Type 1
Free accessResearch articleFirst published online April, 2000
N-[2-(4-Methylphenyl)Ethyl]-N′-[2-(5-Bromopyridyl)]-Thiourea as a Potent Inhibitor of NNRTI-Resistant and Multidrug-Resistant Human Immunodeficiency Virus Type 1
The composite non-nucleoside reverse transcriptase inhibitor (NNRTI) binding pocket model was used to study a number of thiourea analogues with different substitutions at the 4-phenyl position including N-[2-(4-methylphenyl)ethyl]-N′-[2-(5-bromopyridyl)]-thiourea (compound HI-244), which inhibited recombinant RT better than trovirdine or compound HI-275 with an unsubstituted phenyl ring. HI-244 effectively inhibited the replication of HIV-1 strain HTLVIIIB in human peripheral blood mononuclear cells with an IC50 value of 0.007 μM, which is equal to the IC50 value of trovirdine. Notably, HI-244 was 20 times more effective than trovirdine against the multidrug-resistant HIV-1 strain RT-MDR with a V106A mutation (as well as additional mutations involving the RT residues 74 V, 41L and 215Y) and seven times more potent than trovirdine against the NNRTI- resistant HIV-1 strain A17 with a Y181C mutation.
Anonymous (1996) InsightII, computer program. San Diego: Molecular Simulation.
2.
BellFWCantrellASHogbergMJaskunasSRJohanssonNGJordanCLKinnickMDLindPMorinJMJrNoreenRObergBPalkowitzJAParrishCAPrancPSahlbergCTernanskyRTVasileffRTVrangLWestSJZhangH & ZhouXX (1995) Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs. Journal of Medicinal Chemistry38: 4929–4936.
3.
BohmHJ (1992) LUDI: Rule-based automatic design of new substituents for enzyme inhibitor leads. Journal of Computer-Aided Molecular Design6: 593–606.
4.
BohmHJ (1994) The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. Journal of Computer-Aided Molecular Design8: 243–256.
5.
ConnollyML (1983) Solvent-accessible surfaces of proteins and nucleic acids. Science221: 709–713.
6.
DasKDingJHsiouYClarkADJrMoereelsHKoymansLAndriesKPauwelsRJanssenPABoyerPLClarkPSmithRHJrSmithKroeger MBMichejdaCJHughesSH & ArnoldE (1996) Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. Journal of Molecular Biology264: 1085–1100.
7.
EriceALielerCLMeyersDESannerundKJIrvinJDBalfourHH & UckunFM (1993) Inhibition of zidovudine (AZT)-sensitive strains of human immunodeficiency virus type 1 by pokeweed antiviral protein targeted to CD4+ cells. Antimicrobial Agents and Chemotherapy37: 835–838.
8.
LarderBAKellamP & KempSD (1993) Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro. Nature365: 451–453.
9.
MaoCSudbeckEAVenkatachalamTK & UckunFM (1999) Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus. Bioorganic and Medicinal Chemistry Letters9: 1593–1598.
10.
MaoCVigRVenkatachalamTKSudbeckEA & UckunFM (1998) Structure-based design of N-[2-(1-piperidinylethyl)-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. Bioorganic and Medicinal Chemistry Letters8: 2213–2218.
11.
MilesSA (1997) HIV infection and AIDS: New biology, therapeutic advances, and clinical implications. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology16 (Suppl. 1): S1–S2.
12.
RichmanDShihCKLowyIRoseJProdanovicPGoffS & GriffinJ (1991) Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proceedings of the National Academy of Sciences of the USA88: 11241–11245.
13.
SudbeckEAMaoCVigRVenkatachalamTKTuel-AhlgrenL & UckunFM (1998) Structure-based design of novel dihydroalkoxy-benzyloxopyrimidine (DABO) derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Antimicrobial Agents and Chemotherapy3225–3233.
14.
UckunFMChelstromLMTuel-AhlgrenLDibirdikIIrvinJDChandan-LanglieM & MyersDE (1998) TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Antimicrobial Agents and Chemotherapy42: 383–388.
15.
VigRMaoCVenkatachalamTKTuel-AhlgrenLSudbeckEA & UckunFM (1998) Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorganic and Medicinal Chemistry Letters6: 1789–1797.
16.
ZarlingJMMoranPAHaffarOSiasJRichmanDDSpinaCAMyersDEKuebelbeckVLedbetterJA & UckunFM (1990) Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature347: 92–95.
